Commentary

Commentary

This Drug Patent Bill Would Hurt Innovation Without Lowering Prices

This week, the Senate Committee on Health, Education, Labor and Pensions will consider several bills that aim to “make health care more affordable and accessible to American families.” One in particular deserves a closer look. The Medication Affordability and Patent Integrity Act, introduced by Sen. Maggie Hassan, D-N.H., and co-sponsored ...
Commentary

Obamacare’s Enrollment Figures Deserve A Closer Look

Enrollment on the Obamacare exchanges is falling for the first time in years. The exchanges launched on January 1, 2014—nearly four years after President Obama signed the Affordable Care Act into law on March 23, 2010. A new analysis from KFF estimates that the number of people enrolled in an ...
Commentary

Trump Should Stand Firm Against Europe’s Drug Price Free-Riders

For decades, wealthy foreign governments have left it to Americans to pay for pharmaceutical innovation — and then insisted on enjoying the fruits of that innovation at a discount. President Trump has begun challenging that status quo through trade negotiations designed to pressure foreign countries into paying more for innovative ...
Commentary

Medicaid’s fraud problem has become impossible to ignore

The House Energy and Commerce Committee is demanding records from 11 states as part of a widening investigation into potential Medicaid fraud. It’s just the latest sign that Washington is beginning to recognize the scale of abuse inside one of the nation’s largest entitlement programs. The Centers for Medicare and ...
Commentary

Americans Get Medicines First – Why?

Americans hear a lot these days about how Europe has healthcare all figured out. Progressives love pointing to countries like Britain, France, and Canada as models America should follow — especially when it comes to prescription drug prices. What they rarely mention is the price those countries pay for government-controlled ...
Commentary

AOC Says Single-Payer Is Forever – That’s the Problem

“Presidents come and go,” Rep. Alexandria Ocasio-Cortez, D-N.Y., recently declared. “Single-payer is forever.” That line was meant as a boast. Americans should hear it as a warning. For years, progressives have treated government-run healthcare as the ultimate political prize. Sen. Bernie Sanders, I-Vt., made Medicare for All the centerpiece of ...
Commentary

Washington Is Finally Taking Medicaid Fraud More Seriously

Vice President J.D. Vance recently intensified the Trump administration’s crackdown on healthcare fraud, warning states that they could risk losing federal Medicaid funding if they don’t adequately police abuse within the program. The Centers for Medicare and Medicaid Services has also announced a nationwide six-month freeze on new Medicare enrollments ...
Commentary

Read the latest from Sally Pipes on Obamacare

Mark Cuban Is Right About ‘Big Medicine,’ but Wrong About the Cure

He’s hardly alone. Sen. Elizabeth Warren, D-Mass., and Rep. Alexandria Ocasio-Cortez, D-N.Y., among others, are targeting vertically integrated healthcare giants as drivers of rising costs and declining competition. They’re right about one thing — “big medicine” is real. But the healthcare giants they now condemn are, in large part, creatures ...
Commentary

Read the latest from Sally Pipes on government-run health care

Democrats’ latest healthcare fantasy would mean longer waits

First came Obamacare. Now, some on the Left are trying to take the next step toward socialized medicine — “free” primary care for all. A new report from the Searchlight Institute, authored by several architects of the Affordable Care Act, urges Democratic policymakers to guarantee primary care with no out-of-pocket ...
Commentary

Read the latest on drug innovation from Sally Pipes

Big Medical Breakthroughs Start With Small Gains

That may not sound like much. For someone facing a terminal diagnosis, what difference does a few extra months really make, especially if the drugs that enable them cost tens of thousands of dollars, as so many cancer drugs do? That question misses the point. In medicine, the most important ...
Commentary

This Drug Patent Bill Would Hurt Innovation Without Lowering Prices

This week, the Senate Committee on Health, Education, Labor and Pensions will consider several bills that aim to “make health care more affordable and accessible to American families.” One in particular deserves a closer look. The Medication Affordability and Patent Integrity Act, introduced by Sen. Maggie Hassan, D-N.H., and co-sponsored ...
Commentary

Obamacare’s Enrollment Figures Deserve A Closer Look

Enrollment on the Obamacare exchanges is falling for the first time in years. The exchanges launched on January 1, 2014—nearly four years after President Obama signed the Affordable Care Act into law on March 23, 2010. A new analysis from KFF estimates that the number of people enrolled in an ...
Commentary

Trump Should Stand Firm Against Europe’s Drug Price Free-Riders

For decades, wealthy foreign governments have left it to Americans to pay for pharmaceutical innovation — and then insisted on enjoying the fruits of that innovation at a discount. President Trump has begun challenging that status quo through trade negotiations designed to pressure foreign countries into paying more for innovative ...
Commentary

Medicaid’s fraud problem has become impossible to ignore

The House Energy and Commerce Committee is demanding records from 11 states as part of a widening investigation into potential Medicaid fraud. It’s just the latest sign that Washington is beginning to recognize the scale of abuse inside one of the nation’s largest entitlement programs. The Centers for Medicare and ...
Commentary

Americans Get Medicines First – Why?

Americans hear a lot these days about how Europe has healthcare all figured out. Progressives love pointing to countries like Britain, France, and Canada as models America should follow — especially when it comes to prescription drug prices. What they rarely mention is the price those countries pay for government-controlled ...
Commentary

AOC Says Single-Payer Is Forever – That’s the Problem

“Presidents come and go,” Rep. Alexandria Ocasio-Cortez, D-N.Y., recently declared. “Single-payer is forever.” That line was meant as a boast. Americans should hear it as a warning. For years, progressives have treated government-run healthcare as the ultimate political prize. Sen. Bernie Sanders, I-Vt., made Medicare for All the centerpiece of ...
Commentary

Washington Is Finally Taking Medicaid Fraud More Seriously

Vice President J.D. Vance recently intensified the Trump administration’s crackdown on healthcare fraud, warning states that they could risk losing federal Medicaid funding if they don’t adequately police abuse within the program. The Centers for Medicare and Medicaid Services has also announced a nationwide six-month freeze on new Medicare enrollments ...
Commentary

Read the latest from Sally Pipes on Obamacare

Mark Cuban Is Right About ‘Big Medicine,’ but Wrong About the Cure

He’s hardly alone. Sen. Elizabeth Warren, D-Mass., and Rep. Alexandria Ocasio-Cortez, D-N.Y., among others, are targeting vertically integrated healthcare giants as drivers of rising costs and declining competition. They’re right about one thing — “big medicine” is real. But the healthcare giants they now condemn are, in large part, creatures ...
Commentary

Read the latest from Sally Pipes on government-run health care

Democrats’ latest healthcare fantasy would mean longer waits

First came Obamacare. Now, some on the Left are trying to take the next step toward socialized medicine — “free” primary care for all. A new report from the Searchlight Institute, authored by several architects of the Affordable Care Act, urges Democratic policymakers to guarantee primary care with no out-of-pocket ...
Commentary

Read the latest on drug innovation from Sally Pipes

Big Medical Breakthroughs Start With Small Gains

That may not sound like much. For someone facing a terminal diagnosis, what difference does a few extra months really make, especially if the drugs that enable them cost tens of thousands of dollars, as so many cancer drugs do? That question misses the point. In medicine, the most important ...
Scroll to Top